| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Yan Li | |
| Yutaka Yonemura | |||
| Masahiro Miura | |||
| Mitsumasa Hirano | |||
| Akiyoshi Mizumoto | |||
| Yoshio Endou | |||
| Masumi Ichinose | |||
| Nobuyuki Takao | |||
| Ayman Elnemr | |||
| P2860 | cites work | Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer | Q24244876 |
| Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer | Q33357886 | ||
| Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Grou | Q33388301 | ||
| Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy | Q33416610 | ||
| 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer | Q33487198 | ||
| Successful management of microscopic residual disease in large bowel cancer | Q33651971 | ||
| Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure | Q33855586 | ||
| Effective therapy for peritoneal dissemination in gastric cancer | Q35563245 | ||
| Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents. | Q35563258 | ||
| Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy | Q36040207 | ||
| How do cells respond to their thermal environment? | Q36336615 | ||
| Quantitative prognostic indicators of peritoneal dissemination of gastric cancer | Q36450287 | ||
| Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer | Q36614109 | ||
| Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer | Q36673543 | ||
| Cytoreduction and intraperitoneal chemotherapy for carcinomatosis from gastric cancer | Q36882815 | ||
| A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. | Q36892244 | ||
| Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastroesophageal junction: evolution of the docetaxel, cisplatin, and 5-fluorouracil regimen | Q37214866 | ||
| Synergistic antiproliferative effect of mTOR inhibitors in combination with 5-fluorouracil in scirrhous gastric cancer | Q39797811 | ||
| Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer | Q40548259 | ||
| Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. | Q40698258 | ||
| Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer | Q41673474 | ||
| Laparoscopic staging of peritoneal surface malignancies | Q42690469 | ||
| Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery | Q43288249 | ||
| Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer | Q43534629 | ||
| Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial | Q43747422 | ||
| 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer | Q43941230 | ||
| Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy. | Q43958960 | ||
| Thermal Enhancement of New Chemotherapeutic Agents at Moderate Hyperthermia | Q44431967 | ||
| Effect of intraperitoneal chemotherapy on experimental peritoneal dissemination of gastric cancer | Q46826021 | ||
| Hyperthermia and platinum complexes: Time between treatments and synergyin vitroandin vivo | Q50760402 | ||
| Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. | Q51636076 | ||
| Population pharmacokinetics of cisplatin in patients with advanced ovarian cancer during intraperitoneal hyperthermia chemotherapy. | Q52034996 | ||
| Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy. | Q52517952 | ||
| Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. | Q53286355 | ||
| Is PET-CT suitable for predicting lymph node status for gastric cancer? | Q53405079 | ||
| The diagnostic value of PET-CT for peritoneal dissemination of abdominal malignancies. | Q53505025 | ||
| The natural history of free cancer cells in the peritoneal cavity. | Q54253432 | ||
| [Clinical development of S-1 (TS-1) for advanced gastric cancer] | Q57212933 | ||
| Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies | Q68353048 | ||
| Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy | Q69609509 | ||
| Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors | Q69935981 | ||
| Intraperitoneal chemotherapy | Q70172646 | ||
| In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C | Q70645905 | ||
| Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma | Q73097148 | ||
| Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer | Q75244449 | ||
| Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study | Q77553200 | ||
| Intraperitoneal chemo-hyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis | Q77869169 | ||
| Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment | Q78128678 | ||
| Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer | Q79150738 | ||
| Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons | Q79778293 | ||
| Distribution of free cancer cells in the abdominal cavity suggests limitations of bursectomy as an essential component of radical surgery for gastric carcinoma | Q79863794 | ||
| Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival? | Q81688223 | ||
| Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis | Q82810703 | ||
| Neoadjuvant treatment of gastric cancer with peritoneal dissemination | Q83169040 | ||
| Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care? | Q95811506 | ||
| P433 | issue | 2 | |
| P921 | main subject | peritoneal carcinomatosis | Q2071182 |
| P304 | page(s) | 85-97 | |
| P577 | publication date | 2010-02-01 | |
| P1433 | published in | World journal of gastrointestinal oncology | Q27723329 |
| P1476 | title | Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer | |
| P478 | volume | 2 |
| Q89953671 | A critical analysis of the cytoreductive surgery with hyperthermic intraperitoneal chemotherapy combo in the clinical management of advanced gastric cancer: an effective multimodality approach with scope for improvement |
| Q26774528 | Advanced gastric cancer: What we know and what we still have to learn |
| Q64962997 | Advanced gastric cancer: the value of surgery. |
| Q36383695 | Analysis of surgery for incurable gastric cancer |
| Q42269977 | Antitumor Effect of AZD4547 in a Fibroblast Growth Factor Receptor 2-Amplified Gastric Cancer Patient-Derived Cell Model |
| Q26776201 | Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: Intraperitoneal chemotherapy with taxanes |
| Q26768402 | Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy |
| Q35180005 | Clinical significance of zinc-finger E-box binding homeobox 1 mRNA levels in peritoneal washing for gastric cancer |
| Q38116391 | Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States |
| Q26774538 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer |
| Q52690053 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastrointestinal cancers: fad or standard of care? |
| Q64064841 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II) |
| Q38804709 | Diagnostic Laparoscopy in the Pre-operative Assessment of Patients Undergoing Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancies |
| Q38183786 | Drug development for intraperitoneal chemotherapy against peritoneal carcinomatosis from gastrointestinal cancer |
| Q37722146 | Hyperthermic intraperitoneal chemotherapy with mitomycin C and 5-fluorouracil in patients at high risk of peritoneal metastasis from colorectal cancer: A preliminary clinical study |
| Q38800565 | Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis |
| Q92447034 | Long Term Survival after Cytoreductive Surgery Combined with Perioperative Chemotherapy in Gastric Cancer Patients with Peritoneal Metastasis |
| Q34391069 | New approach to peritoneal surface malignancies |
| Q92617955 | Normothermic intraperitoneal chemotherapy long term (NIPEC-LT) in the management of peritoneal surface malignancy, an overview |
| Q38726776 | Oligometastatic Disease in the Peritoneal Space with Gastrointestinal Cancer |
| Q58566712 | Optimizing outcomes for patients with gastric cancer peritoneal carcinomatosis |
| Q53213677 | Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility? |
| Q28067269 | Regional but fatal: Intraperitoneal metastasis in gastric cancer |
| Q38944087 | Selection criteria for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer |
| Q53197945 | Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T). |
| Q90321326 | Surgical management of metastatic gastric cancer: moving beyond the guidelines |
| Q37798985 | Surgical treatment for peritoneal carcinomatosis from gastric cancer |
| Q92617822 | Survival outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from gastric cancer: a systematic review |
| Q36758921 | The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer. |
| Q93149220 | The Value of Serum Immunoglobulin G Glycome in the Preoperative Discrimination of Peritoneal Metastasis from Advanced Gastric Cancer |
| Q36640439 | The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer |
| Q38201470 | The treatment of peritoneal carcinomatosis in advanced gastric cancer: state of the art. |
Search more.